Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Chappell JC, Turner PK, Pak YA, Bacon J, Chiang AY, Royalty J, et al
The therapeutic effects of TGR5 agonists could be improved in combinatorial therapy
As oxidative damage accumulates, demand for potent antioxidants like oxidized glutathione has surged
Substances delivered intravenously bypass the digestive system, preventing any losses that might occur due to metabolism in the digestive tract
10.1186/s13054-020-03158-0 Summary Keywords COVID-19, cytokine release syndrome, MIS-C, TNF- inhibitor, infliximab Citation Guo Y, Hu K, Li Y, Lu C, Ling K, Cai C, Wang W and Ye D (2022) Targeting TNF- for COVID-19: Recent Advanced and Controversies
US$ 21.58
US$ 23.09
US$ 25.64
US$ 20.79
US$ 25.98
US$ 29.57
US$ 27.71
US$ 22.38
US$ 20.84
